Cellerix Raises €27 Million
Cellerix SL, a Tres Cantos, Spain-based developer of adult stem cell therapies, has raised €27 million in a first close on its Series C round. Ysios Capital Partners and Ventech co-led the tranche, and were joined by fellow return backers Roche Venture Fund and Novartis Venture Fund. The company previously raised a €27.2 million round in September 2007.
12 November 2009•2 mins read
